|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000139044 |
Summary for B4GALNT3 |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000139044 | Gene symbol | B4GALNT3 |
| Gene name | beta-1,4-N-acetyl-galactosaminyltransferase 3 | |
| HGNC | 24137 | |
| Entrez ID | 283358 | |
| Gene type | protein_coding | |
| Synonyms | B4GALNT3|B4GalNac-T3|FLJ16224|FLJ40362 | |
| UniProtAcc | Q6L9W6 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for B4GALNT3 |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| B4GALNT3 | 6.49e+02 | 1.17e+00 | 2.54e-01 | 4.60e+00 | 4.30e-06 | 1.66e-04 | SARC |
| Differentially expressed gene analysis between tumor male and normal male samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| B4GALNT3 | 3.60e+03 | 1.03e+00 | 2.33e-01 | 4.43e+00 | 9.47e-06 | 1.75e-05 | LUSC |
| B4GALNT3 | 6.43e+03 | -1.60e+00 | 4.00e-01 | -4.00e+00 | 6.21e-05 | 6.79e-04 | ESCA |
| B4GALNT3 | 1.08e+03 | 3.94e+00 | 7.36e-01 | 5.36e+00 | 8.39e-08 | 7.71e-07 | CHOL |
| Differentially expressed gene analysis between tumor female and normal female samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| B4GALNT3 | 3.46e+03 | 1.03e+00 | 2.09e-01 | 4.94e+00 | 7.63e-07 | 2.31e-06 | LUAD |
| B4GALNT3 | 4.47e+03 | -1.39e+00 | 3.95e-01 | -3.52e+00 | 4.31e-04 | 2.88e-03 | STAD |
| B4GALNT3 | 2.62e+03 | -1.12e+00 | 1.96e-01 | -5.73e+00 | 1.02e-08 | 4.68e-08 | COAD |
| B4GALNT3 | 1.84e+03 | 1.74e+00 | 1.38e-01 | 1.26e+01 | 1.37e-36 | 8.92e-36 | BRCA |
Top |
Sex-biased somatic mutation for B4GALNT3 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for B4GALNT3 |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg26388816 | chr12:460989 | CGI:chr12:459536-461196 | promoter,gene body | 4.98e-01 | 7.64e-01 | -2.68e+00 | 7.27e-03 | 2.36e-02 | -2.65e-01 |
| BRCA | cg20907806 | chr12:461083 | CGI:chr12:459536-461196 | promoter,gene body | 4.25e-01 | 5.54e-01 | -2.26e+00 | 2.38e-02 | 3.74e-02 | -1.29e-01 |
| MESO | cg26388816 | chr12:460989 | CGI:chr12:459536-461196 | promoter,gene body | 1.67e-01 | 3.09e-01 | -2.02e+00 | 4.34e-02 | 4.84e-02 | -1.42e-01 |
| ACC | cg26388816 | chr12:460989 | CGI:chr12:459536-461196 | promoter,gene body | 2.24e-01 | 3.24e-01 | -1.99e+00 | 4.68e-02 | 4.83e-02 | -1.01e-01 |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| COAD | cg10248279 | chr12:459377 | CGI:chr12:459536-461196 | promoter | 6.08e-01 | 7.78e-01 | -2.80e+00 | 5.11e-03 | 8.40e-03 | -1.70e-01 |
| LIHC | cg05769161 | chr12:459660 | CGI:chr12:459536-461196 | promoter | 1.56e-01 | 3.75e-02 | 2.90e+00 | 3.71e-03 | 5.07e-03 | 1.18e-01 |
| LIHC | cg11065385 | chr12:459632 | CGI:chr12:459536-461196 | promoter | 2.89e-01 | 1.65e-01 | 1.98e+00 | 4.78e-02 | 4.80e-02 | 1.24e-01 |
| CHOL | cg10248279 | chr12:459377 | CGI:chr12:459536-461196 | promoter | 5.29e-01 | 7.38e-01 | -2.43e+00 | 1.50e-02 | 2.65e-02 | -2.09e-01 |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg10248279 | chr12:459377 | CGI:chr12:459536-461196 | promoter | 3.46e-01 | 4.66e-01 | -5.88e+00 | 4.06e-09 | 9.37e-09 | -1.20e-01 |
| LUAD | cg10248279 | chr12:459377 | CGI:chr12:459536-461196 | promoter | 4.92e-01 | 6.18e-01 | -2.68e+00 | 7.30e-03 | 1.26e-02 | -1.26e-01 |
| THCA | cg10248279 | chr12:459377 | CGI:chr12:459536-461196 | promoter | 4.51e-01 | 5.86e-01 | -3.97e+00 | 7.19e-05 | 2.39e-04 | -1.35e-01 |
| HNSC | cg10248279 | chr12:459377 | CGI:chr12:459536-461196 | promoter | 6.71e-01 | 4.55e-01 | 2.34e+00 | 1.92e-02 | 2.69e-02 | 2.16e-01 |
Top |
Exon skipping events with PSI in TCGA for B4GALNT3 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Landscape of exon skipping events across multiple cancer types. |
 |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for B4GALNT3 |
| ∗Please access CAeditome for RNA editing annotation. |
| Landscape of RNA editing events across multiple cancer types. |
 |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| COAD | B4GALNT3-002 | chr12_482740_+ | 3.88e-01 | 7.45e-01 | -2.70e+00 | 6.95e-03 | 1.84e-02 | -3.57e-01 |
| STAD | B4GALNT3-002 | chr12_496901_+ | 4.15e-01 | 2.84e-01 | 2.24e+00 | 2.53e-02 | 4.96e-02 | 1.31e-01 |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for B4GALNT3 |
| TFs related to B4GALNT3. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| B4GALNT3 related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for B4GALNT3 |
| RBPs related to ES in B4GALNT3. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| STAD | BRUNOL6 | exon_skip_78875 | 8.42e+00 | 6.51e-03 | 8.81e+00 | 9.89e-01 | Female-biased |
| KICH | BRUNOL6 | exon_skip_78875 | 8.83e+00 | 9.84e-01 | 8.52e+00 | 1.06e-02 | Male-biased |
| B4GALNT3 related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
| ENSG00000139044 | SPINT1-AS1,hsa-mir-7110,B4GALNT3 | Female-specific ceRNA | TCGA-LIHC |
| ENSG00000139044 | TMEM72-AS1,hsa-mir-7110,B4GALNT3 | Female-specific ceRNA | TCGA-LIHC |
| ENSG00000139044 | AC048341.1,hsa-mir-7110,B4GALNT3 | Female-specific ceRNA | TCGA-LIHC |
| ENSG00000139044 | KCCAT198,hsa-mir-7110,B4GALNT3 | Female-specific ceRNA | TCGA-LIHC |
| ENSG00000139044 | DLEU2L,hsa-mir-7110,B4GALNT3 | Female-specific ceRNA | TCGA-LIHC |
| ENSG00000139044 | AL353997.2,hsa-mir-506,B4GALNT3 | Male-specific ceRNA | TCGA-LUSC |
| ENSG00000139044 | LINC01630,hsa-mir-211,B4GALNT3 | Tumor sex-biased ceRNA | TCGA-SARC |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs4764521 | chr12:5975157:A:G | - | -0.242688041320613 | 0.0407128386708795 | PAAD | Female-baised eQTL |
| rs12821197 | chr12:7857034:G:A | - | 0.119350986068262 | 0.000515571519236452 | KIRC | Female-baised eQTL |
| rs10848692 | chr12:2708776:T:C | - | 0.0781243410546768 | 0.010113980341951 | KIRC | Female-baised eQTL |
| rs11062324 | chr12:2708419:G:C | - | 0.0760809982809752 | 0.0133186555231405 | KIRC | Female-baised eQTL |
| rs7305595 | chr12:3453068:G:A | - | 0.088292912684001 | 0.015126688396388 | KIRC | Female-baised eQTL |
| rs4766061 | chr12:3183166:A:G | - | -0.140889091881303 | 0.00745376921557698 | BLCA | Female-baised eQTL |
| rs2110171 | chr12:5818663:A:G | - | -0.187542227592398 | 0.0157354090420062 | BLCA | Female-baised eQTL |
| rs73051250 | chr12:5999524:T:C | - | 0.107427382189753 | 0.0206844753977145 | BLCA | Female-baised eQTL |
| rs56008400 | chr12:6003408:A:G | - | 0.107314108688811 | 0.0218967468155397 | BLCA | Female-baised eQTL |
| rs10219599 | chr12:6003972:C:A | - | 0.107314108688811 | 0.0218967468155397 | BLCA | Female-baised eQTL |
| rs55999991 | chr12:6004173:T:C | - | 0.107314108688811 | 0.0218967468155397 | BLCA | Female-baised eQTL |
| rs2058032 | chr12:1664983:T:C | - | -0.138946267425986 | 0.0220238681172793 | BLCA | Female-baised eQTL |
| rs73052781 | chr12:7605777:A:C | - | 0.144694665141683 | 0.0338487283088146 | BLCA | Female-baised eQTL |
| rs61291672 | chr12:2405550:A:G | - | 0.0693170043669853 | 0.00635353515822653 | LUAD | Female-baised eQTL |
| rs11837034 | chr12:2400140:T:G | - | 0.0529300461588785 | 0.00966263945137762 | LUAD | Female-baised eQTL |
| rs61907810 | chr12:2401857:C:T | - | 0.0507970005134497 | 0.017164780220177 | LUAD | Female-baised eQTL |
| rs11829249 | chr12:2403438:A:G | - | 0.0516319534882658 | 0.0171769185770232 | LUAD | Female-baised eQTL |
| rs4562883 | chr12:2403710:C:T | - | 0.0516319534882658 | 0.0171769185770232 | LUAD | Female-baised eQTL |
| rs7294604 | chr12:2403862:T:C | - | 0.0516319534882658 | 0.0171769185770232 | LUAD | Female-baised eQTL |
| rs7136865 | chr12:2404122:A:G | - | 0.0516492487786522 | 0.0172373908539075 | LUAD | Female-baised eQTL |
| rs11831085 | chr12:2405692:A:G | - | 0.0513129642939738 | 0.0185091242805051 | LUAD | Female-baised eQTL |
| rs59679560 | chr12:2406664:A:G | - | 0.0513129642939738 | 0.0185091242805051 | LUAD | Female-baised eQTL |
| rs2159059 | chr12:2405978:C:G | - | 0.0513785037824179 | 0.0189495347835949 | LUAD | Female-baised eQTL |
| rs11836545 | chr12:2400442:A:G | - | 0.0486041281719113 | 0.0195161547935083 | LUAD | Female-baised eQTL |
| rs11837126 | chr12:2400484:T:G | - | 0.0486041281719113 | 0.0195161547935083 | LUAD | Female-baised eQTL |
| rs7301013 | chr12:2399405:A:G | - | 0.0486019952848377 | 0.0206235832321663 | LUAD | Female-baised eQTL |
| rs7973812 | chr12:2394826:T:C | - | 0.048765745260334 | 0.0248087736217378 | LUAD | Female-baised eQTL |
| rs7306871 | chr12:8558120:G:A | - | 0.070375855301945 | 0.0294832466715299 | LUAD | Female-baised eQTL |
| rs6487247 | chr12:8558423:C:T | - | 0.0700526462967822 | 0.0311166615659678 | LUAD | Female-baised eQTL |
| rs7295518 | chr12:8557603:T:C | - | 0.0677096827302867 | 0.0395531973038846 | LUAD | Female-baised eQTL |
| rs7295916 | chr12:8557903:T:C | - | 0.0677096827302867 | 0.0395531973038846 | LUAD | Female-baised eQTL |
| rs73059703 | chr12:7317746:C:T | - | 0.0434602532620313 | 0.043619962984298 | LUAD | Female-baised eQTL |
| rs73059705 | chr12:7323014:T:C | - | 0.0434602532620313 | 0.043619962984298 | LUAD | Female-baised eQTL |
| rs73057799 | chr12:7317423:G:A | - | 0.043846165162678 | 0.0453731561388829 | LUAD | Female-baised eQTL |
| rs75877706 | chr12:8553778:G:A | - | 0.0660209775898981 | 0.0457542907810447 | LUAD | Female-baised eQTL |
| rs112548699 | chr12:8556966:T:A | - | 0.0658947936125694 | 0.0466063466992243 | LUAD | Female-baised eQTL |
| rs73059709 | chr12:7325842:T:C | - | 0.0430887629348126 | 0.0466194619373504 | LUAD | Female-baised eQTL |
| rs112493235 | chr12:7331103:C:T | - | 0.0430887629348126 | 0.0466194619373504 | LUAD | Female-baised eQTL |
| rs7488587 | chr12:7332213:C:T | - | 0.0430887629348126 | 0.0466194619373504 | LUAD | Female-baised eQTL |
| rs4883255 | chr12:7332984:C:T | - | 0.0430887629348126 | 0.0466194619373504 | LUAD | Female-baised eQTL |
| rs370603663 | chr12:7334173:C:T | - | 0.0430887629348126 | 0.0466194619373504 | LUAD | Female-baised eQTL |
| rs7488684 | chr12:7336932:T:C | - | 0.0430887629348126 | 0.0466194619373504 | LUAD | Female-baised eQTL |
| rs113415391 | chr12:8556704:A:C | - | 0.0658420435430641 | 0.0470753844912022 | LUAD | Female-baised eQTL |
| rs74741051 | chr12:8556919:T:C | - | 0.0658420435430641 | 0.0470753844912022 | LUAD | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs11613749 | chr12:3599333:C:T | - | 0.136072627939534 | 0.00418164940178207 | PAAD | Male-baised eQTL |
| rs763555 | chr12:1937116:C:G | - | 0.0945050206680179 | 0.0497553532122738 | PAAD | Male-baised eQTL |
| rs73041038 | chr12:1140486:G:A | - | 0.113760781265079 | 0.00483783142767322 | HNSC | Male-baised eQTL |
| rs73041040 | chr12:1142730:G:C | - | 0.112080076937523 | 0.00649441517228406 | HNSC | Male-baised eQTL |
| rs73041048 | chr12:1156429:G:A | - | 0.112488271626884 | 0.00659520780728764 | HNSC | Male-baised eQTL |
| rs2968898 | chr12:1135059:G:T | - | -0.0788425916402963 | 0.0128026608120309 | HNSC | Male-baised eQTL |
| rs60139771 | chr12:4597049:A:G | - | 0.101657231864486 | 0.000385703484440644 | KIRP | Male-baised eQTL |
| rs58057028 | chr12:4597317:C:A | - | 0.101657231864486 | 0.000385703484440644 | KIRP | Male-baised eQTL |
| rs61909651 | chr12:4600314:C:T | - | 0.0977820160093769 | 0.000767040800505309 | KIRP | Male-baised eQTL |
| rs3782600 | chr12:5626643:T:C | - | 0.0846672305002389 | 0.0351384036340862 | KIRP | Male-baised eQTL |
| rs4486677 | chr12:8516520:T:G | - | 0.0811356745431863 | 0.0359328380072896 | STAD | Male-baised eQTL |
| rs11045983 | chr12:8513522:A:T | - | 0.0802249540123796 | 0.0389370113660579 | STAD | Male-baised eQTL |
| rs147976261 | chr12:8524200:T:C | - | 0.0832441212797021 | 0.0410579650039827 | STAD | Male-baised eQTL |
| rs57832572 | chr12:8515685:G:A | - | 0.079010518791989 | 0.0475958675458174 | STAD | Male-baised eQTL |
| rs139777065 | chr12:2123136:G:C | - | 0.0791907677410288 | 0.00675378073456968 | KIRC | Male-baised eQTL |
| rs4765880 | chr12:2031459:T:C | - | 0.0681715840227792 | 0.0401412821206379 | KIRC | Male-baised eQTL |
| rs7311644 | chr12:4689884:A:G | - | -0.0756359438612165 | 0.00293694359523654 | BLCA | Male-baised eQTL |
| rs11063222 | chr12:487446:C:T | gene | 0.0615113823241097 | 0.00437503761042512 | BLCA | Male-baised eQTL |
| rs10849084 | chr12:486376:A:G | gene | 0.0587640110122633 | 0.00449816921157488 | BLCA | Male-baised eQTL |
| rs10849088 | chr12:487893:G:A | gene | 0.0587640110122633 | 0.00449816921157488 | BLCA | Male-baised eQTL |
| rs7138646 | chr12:493036:A:T | gene | 0.0554360550494 | 0.0109979220270517 | BLCA | Male-baised eQTL |
| rs11063233 | chr12:489796:C:T | gene | 0.0528001985573829 | 0.0113986770323342 | BLCA | Male-baised eQTL |
| rs11513717 | chr12:490282:G:A | gene | 0.0528001985573829 | 0.0113986770323342 | BLCA | Male-baised eQTL |
| rs10849099 | chr12:490700:C:T | gene | 0.0528001985573829 | 0.0113986770323342 | BLCA | Male-baised eQTL |
| rs12369151 | chr12:492050:C:T | gene | 0.0526551278515551 | 0.0118923808299934 | BLCA | Male-baised eQTL |
| rs11063252 | chr12:492418:G:A | gene | 0.0526551278515551 | 0.0118923808299934 | BLCA | Male-baised eQTL |
| rs10774240 | chr12:488959:G:A | gene | 0.0524899841457311 | 0.0125061898095466 | BLCA | Male-baised eQTL |
| rs11063226 | chr12:488556:A:G | gene | 0.0471418668900966 | 0.0297333734431965 | BLCA | Male-baised eQTL |
| rs7971615 | chr12:496270:A:T | gene | 0.055193168945242 | 0.0413743716804194 | BLCA | Male-baised eQTL |
| rs12228043 | chr12:497494:G:A | gene | 0.0551793407342612 | 0.0414818221312342 | BLCA | Male-baised eQTL |
| rs34458614 | chr12:7123098:G:C | - | 0.0494171225610449 | 0.0464166404329525 | BLCA | Male-baised eQTL |
| rs12829025 | chr12:7125414:C:A | - | 0.0492946459197753 | 0.047627956367916 | BLCA | Male-baised eQTL |
| rs12823996 | chr12:3873309:C:T | - | 0.0583131289888644 | 0.0433769427189087 | LUAD | Male-baised eQTL |
| rs2724212 | chr12:4074630:C:G | - | 0.0912775524378344 | 2.96375117249345e-07 | COAD | Male-baised eQTL |
| rs143860788 | chr12:6083469:G:A | - | 0.0638910586015728 | 0.000592999446681407 | COAD | Male-baised eQTL |
| rs11836708 | chr12:6085491:G:C | - | 0.0603990800595099 | 0.000610503925520245 | COAD | Male-baised eQTL |
| rs142710889 | chr12:6088406:G:A | - | 0.0588600438888533 | 0.000875914638147265 | COAD | Male-baised eQTL |
| rs6489544 | chr12:474376:A:G | gene | -0.0710830345493378 | 0.00113009700386247 | COAD | Male-baised eQTL |
| rs478455 | chr12:186380:A:G | - | 0.0436602018672001 | 0.00415088190726143 | COAD | Male-baised eQTL |
| rs12372671 | chr12:6740262:G:A | - | 0.057283939163708 | 0.00550707832523956 | COAD | Male-baised eQTL |
| rs61916014 | chr12:9066603:C:T | - | 0.0634807877494589 | 0.00585596446280354 | COAD | Male-baised eQTL |
| rs11063642 | chr12:5390936:C:T | - | 0.06032009999347 | 0.0126626436189771 | COAD | Male-baised eQTL |
| rs79879554 | chr12:6054972:G:A | - | 0.0496501170896722 | 0.0171963354823729 | COAD | Male-baised eQTL |
| rs11063641 | chr12:5387429:T:G | - | 0.0574237619897965 | 0.0190609847841008 | COAD | Male-baised eQTL |
| rs56083830 | chr12:5000201:C:G | - | 0.0468895114590492 | 0.0210085962495742 | COAD | Male-baised eQTL |
| rs4763462 | chr12:10203252:T:C | - | -0.0334221228634276 | 0.0241522298378382 | COAD | Male-baised eQTL |
| rs12306188 | chr12:315543:C:A | - | 0.0536616461795776 | 0.026742886445505 | COAD | Male-baised eQTL |
| rs57580513 | chr12:315869:G:A | - | 0.0536616461795776 | 0.026742886445505 | COAD | Male-baised eQTL |
| rs1017162 | chr12:316797:T:C | - | 0.0536616461795776 | 0.026742886445505 | COAD | Male-baised eQTL |
| rs12303378 | chr12:318965:C:T | - | 0.0536616461795776 | 0.026742886445505 | COAD | Male-baised eQTL |
| rs1541584 | chr12:321709:A:T | - | 0.0536616461795776 | 0.026742886445505 | COAD | Male-baised eQTL |
| rs3815557 | chr12:323477:G:A | - | 0.0536616461795776 | 0.026742886445505 | COAD | Male-baised eQTL |
| rs2300130 | chr12:330464:T:C | - | 0.0536616461795776 | 0.026742886445505 | COAD | Male-baised eQTL |
| rs16929851 | chr12:333919:C:A | - | 0.0536616461795776 | 0.026742886445505 | COAD | Male-baised eQTL |
| rs12298836 | chr12:335917:C:T | - | 0.0536616461795776 | 0.026742886445505 | COAD | Male-baised eQTL |
| rs11062465 | chr12:336284:G:A | - | 0.0536616461795776 | 0.026742886445505 | COAD | Male-baised eQTL |
| rs720127 | chr12:336571:G:A | - | 0.0536616461795776 | 0.026742886445505 | COAD | Male-baised eQTL |
| rs12314514 | chr12:338207:T:C | - | 0.0536616461795776 | 0.026742886445505 | COAD | Male-baised eQTL |
| rs673762 | chr12:5190906:T:C | - | -0.044582027566243 | 0.0274555833092271 | COAD | Male-baised eQTL |
| rs4238022 | chr12:5373230:A:G | - | -0.0372379008763617 | 0.0276027164133344 | COAD | Male-baised eQTL |
| rs9971725 | chr12:10204763:G:C | - | -0.0328623010705709 | 0.0278491060838744 | COAD | Male-baised eQTL |
| rs7300389 | chr12:6000675:G:A | - | 0.0412348565765963 | 0.0377253725749223 | COAD | Male-baised eQTL |
| rs188819154 | chr12:6000796:A:T | - | 0.0412348565765963 | 0.0377253725749223 | COAD | Male-baised eQTL |
| rs12321546 | chr12:279146:C:T | - | 0.0433409431185041 | 0.04378013882969 | COAD | Male-baised eQTL |
| rs10849114 | chr12:497175:C:T | gene | 0.0422731838395447 | 0.0438763056678649 | COAD | Male-baised eQTL |
| rs10735043 | chr12:5007115:T:A | - | -0.0361238698952311 | 0.0457473762680427 | COAD | Male-baised eQTL |
| rs3931679 | chr12:5011780:C:A | - | -0.0361238698952311 | 0.0457473762680427 | COAD | Male-baised eQTL |
| rs60430553 | chr12:6002270:T:G | - | 0.0407879901224623 | 0.0470184896618466 | COAD | Male-baised eQTL |
| rs61907313 | chr12:5013320:C:T | - | -0.0353094750984331 | 0.0485813453807023 | COAD | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
 | Gene ID: ENSG00000139044 |
| CpG Site: cg20907806 | |
| Position to Gene: gene,promoter | |
| Male Effect: -0.055380663101858 | |
| Female Effect: - |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg20907806 | chr12:461083 | gene,promoter | -0.055380663101858 | 1.10065569172848e-05 | -0.3495751967496201 | 8.274682884743636e-08 | LUAD |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of B4GALNT3 |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
